Aridis Pharmaceuticals (ARDS)
US Market

Aridis Pharmaceuticals Financial Statements

Aridis Pharmaceuticals Financial Overview

Aridis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.787; its P/E ratio is -0.58; Aridis Pharmaceuticals is scheduled to report earnings on August 16, 2022, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 0.00$ -131.00K$ 98.00K$ 33.00K$ 0.00
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -7.42M$ -8.55M$ -21.03M$ -6.23M$ -6.90M
EBITDA$ -7.29M$ -8.39M$ -20.93M$ -6.14M$ -6.81M
Net Income Common Stockholders$ -7.77M$ -8.81M$ -24.14M$ -5.49M$ -7.88M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 3.59M$ 6.21M$ 8.23M$ 10.47M$ 12.47M
Total Assets$ 23.82M$ 26.80M$ 26.09M$ 11.39M$ 17.57M
Total Debt$ 466.00K$ 715.00K$ 964.00K$ 5.91M$ 13.05M
Net Debt$ -3.13M$ -5.50M$ -7.27M$ -4.56M$ 579.00K
Total Liabilities$ 44.23M$ 39.91M$ 30.24M$ 24.87M$ 26.12M
Stockholders Equity$ -20.41M$ -13.11M$ -4.16M$ -13.49M$ -8.55M
Cash Flow
Free Cash Flow$ -10.19M$ -3.69M$ -8.71M$ -6.73M$ -4.34M
Operating Cash Flow$ -10.17M$ -3.73M$ -8.59M$ -6.61M$ -4.01M
Investing Cash Flow$ -21.00K$ 43.00K$ -114.00K$ -124.00K$ -335.00K
Financing Cash Flow$ 4.44M$ 4.95M$ 23.34M$ -149.00K$ 6.58M
Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

Aridis Pharmaceuticals Debt to Assets

Aridis Pharmaceuticals Cash Flow

Aridis Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis